Selvita S.A.

zł 16.36As of Sun 8 Nov 2026, 12:00 UTC
WSE:SLVHealthcare
Country Poland
PE (Fwd) •••
TSR 7Y CAGR (6.07%)
Div yield —
ROE (0.66%)
Diagnostics & Research
Beta (5Y) 0.21
PE TTM —
TSR TTM (55.66%)
Mkt cap zł 300.3M
ROIC 1.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 16
0.06%
(16.63%)
Hold 7|5|6|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.19
0.20
0.22
0.22
25.89%
32.81%
29.50%
21.36%
Revenuezł M
14.11
13.73
14.15
14.02
1.79%
(5.82%)
(2.54%)
(1.44%)
Peers (US$75.84M)
Cap (US$)
PE
400.5M
13.58x
73.07M
—
Capital
TTM
5Y
10Y
Leveragex
0.109
(0.881)
(0.725)
EBIT/Intx
4.859
0.341
0.346
Own earn%
659.97
135.02
132.72
Sh yield%
28.43
20.23
21.11
Owners
Insiders/Inst%
13.29
44.34
Short interest%
5.96
SBC / revenue%
3.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
28–33
$1 testx
—
Incr. ROIC%
6